Search

Redentor M. Pasia

Examiner (ID: 16815, Phone: (571)272-9745 , Office: P/2479 )

Most Active Art Unit
2413
Art Unit(s)
2616, 2413, 2474, 2479, 2416
Total Applications
771
Issued Applications
563
Pending Applications
74
Abandoned Applications
158

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8265774 [patent_doc_number] => 20120165208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => ' METHOD FOR PREDICTING THE RESPONSIVENESS OF A PATIENT TO A TREATMENT WITH AN ANTI-CD20 ANTIBODY AND A METHOD FOR DIAGNOSING RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 13/320054 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7529 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320054 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/320054
METHOD FOR PREDICTING THE RESPONSIVENESS OF A PATIENT TO A TREATMENT WITH AN ANTI-CD20 ANTIBODY AND A METHOD FOR DIAGNOSING RHEUMATOID ARTHRITIS May 17, 2010 Abandoned
Array ( [id] => 8221678 [patent_doc_number] => 20120135882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHODS FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND ASSESSING THE RISK OF DISEASE PROGRESSION' [patent_app_type] => utility [patent_app_number] => 13/320485 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13839 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320485 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/320485
METHODS FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND ASSESSING THE RISK OF DISEASE PROGRESSION May 12, 2010 Abandoned
Array ( [id] => 6530292 [patent_doc_number] => 20100221230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Elective Collection and Banking of Autologous Peripheral Blood Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/775606 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8448 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221230.pdf [firstpage_image] =>[orig_patent_app_number] => 12775606 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/775606
Elective Collection and Banking of Autologous Peripheral Blood Stem Cells May 6, 2010 Abandoned
Array ( [id] => 7791527 [patent_doc_number] => 20120053083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'HEPATOCELLULAR CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/318789 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18242 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053083.pdf [firstpage_image] =>[orig_patent_app_number] => 13318789 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/318789
HEPATOCELLULAR CARCINOMA May 4, 2010 Abandoned
Array ( [id] => 6589757 [patent_doc_number] => 20100291647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/770025 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12127 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291647.pdf [firstpage_image] =>[orig_patent_app_number] => 12770025 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/770025
Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use Apr 28, 2010 Abandoned
Array ( [id] => 6631967 [patent_doc_number] => 20100311811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'RNA-MEDIATED EPIGENETIC REGULATION OF GENE TRANSCRIPTION' [patent_app_type] => utility [patent_app_number] => 12/769434 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 40660 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311811.pdf [firstpage_image] =>[orig_patent_app_number] => 12769434 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/769434
RNA-MEDIATED EPIGENETIC REGULATION OF GENE TRANSCRIPTION Apr 27, 2010 Abandoned
Array ( [id] => 6235384 [patent_doc_number] => 20100267088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'INHA PROMOTERS' [patent_app_type] => utility [patent_app_number] => 12/760827 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11330 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267088.pdf [firstpage_image] =>[orig_patent_app_number] => 12760827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/760827
INHA PROMOTERS Apr 14, 2010 Abandoned
Array ( [id] => 6235389 [patent_doc_number] => 20100267093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/760461 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 40089 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267093.pdf [firstpage_image] =>[orig_patent_app_number] => 12760461 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/760461
ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS Apr 13, 2010 Abandoned
Array ( [id] => 7731629 [patent_doc_number] => 20120014987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'DNA VACCINE FOR ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 13/257713 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014987.pdf [firstpage_image] =>[orig_patent_app_number] => 13257713 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/257713
DNA VACCINE FOR ALZHEIMER'S DISEASE Mar 25, 2010 Abandoned
Array ( [id] => 6294976 [patent_doc_number] => 20100240133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Compositions and Methods for Transposon Mutagenesis of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/728943 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 21665 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240133.pdf [firstpage_image] =>[orig_patent_app_number] => 12728943 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/728943
Enhanced PiggyBac transposon and methods for transposon mutagenesis Mar 21, 2010 Issued
Array ( [id] => 7711751 [patent_doc_number] => 20120004136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 13/256814 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7796 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256814 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/256814
MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER Mar 18, 2010 Abandoned
Array ( [id] => 7778155 [patent_doc_number] => 20120040855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'TISSUE-SPECIFIC AGING BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/138523 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20421 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040855.pdf [firstpage_image] =>[orig_patent_app_number] => 13138523 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/138523
TISSUE-SPECIFIC AGING BIOMARKERS Mar 9, 2010 Abandoned
Array ( [id] => 6264811 [patent_doc_number] => 20100297642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHOD FOR DETERMINING FRAMESHIFT MUTATIONS IN CODING NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/714835 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6720 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297642.pdf [firstpage_image] =>[orig_patent_app_number] => 12714835 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/714835
Method for determining frameshift mutations in coding nucleic acids Feb 28, 2010 Issued
Array ( [id] => 7791520 [patent_doc_number] => 20120053076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS FOR IDENTIFICATION' [patent_app_type] => utility [patent_app_number] => 13/203661 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27075 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053076.pdf [firstpage_image] =>[orig_patent_app_number] => 13203661 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/203661
METHODS FOR IDENTIFICATION Feb 25, 2010 Abandoned
Array ( [id] => 6538235 [patent_doc_number] => 20100221731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer' [patent_app_type] => utility [patent_app_number] => 12/711068 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 27718 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221731.pdf [firstpage_image] =>[orig_patent_app_number] => 12711068 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/711068
Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression Feb 22, 2010 Issued
Array ( [id] => 6538203 [patent_doc_number] => 20100221729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer' [patent_app_type] => utility [patent_app_number] => 12/711036 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 27696 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221729.pdf [firstpage_image] =>[orig_patent_app_number] => 12711036 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/711036
Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer Feb 22, 2010 Abandoned
Array ( [id] => 6538218 [patent_doc_number] => 20100221730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer' [patent_app_type] => utility [patent_app_number] => 12/711056 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 27698 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221730.pdf [firstpage_image] =>[orig_patent_app_number] => 12711056 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/711056
Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer Feb 22, 2010 Abandoned
Array ( [id] => 8313541 [patent_doc_number] => 20120190565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm' [patent_app_type] => utility [patent_app_number] => 13/202312 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 43125 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202312 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/202312
Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm Feb 17, 2010 Abandoned
Array ( [id] => 7807947 [patent_doc_number] => 20120058901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1' [patent_app_type] => utility [patent_app_number] => 13/201296 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27216 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058901.pdf [firstpage_image] =>[orig_patent_app_number] => 13201296 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/201296
ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1 Feb 11, 2010 Abandoned
Array ( [id] => 6149204 [patent_doc_number] => 20110020799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Screening method for damaged DNA repairing substance' [patent_app_type] => utility [patent_app_number] => 12/656408 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9743 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020799.pdf [firstpage_image] =>[orig_patent_app_number] => 12656408 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/656408
Screening method for damaged DNA repairing substance Jan 27, 2010 Abandoned
Menu